A2 Milk Co.'s stock surged 6.71% during intraday trading on Monday, following the announcement of key regulatory and corporate developments.
The company received final approval from China's State Administration for Market Regulation to transfer two China-label infant milk formula registrations linked to its Pokeno facility to the a2 brand. This approval makes the acquisition of the a2 Pokeno facility irrevocable, removing a significant regulatory hurdle.
Additionally, the board is expected to meet soon to consider a NZ$300 million fully franked special dividend, with details to be released upon formal approval. These positive developments have driven investor optimism, leading to the sharp price increase.